These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 19635774)
1. Stability of gabapentin 300-mg capsules repackaged in unit dose containers. Gupta A; Ciavarella AB; Rothman B; Faustino PJ; Khan MA Am J Health Syst Pharm; 2009 Aug; 66(15):1376-80. PubMed ID: 19635774 [TBL] [Abstract][Full Text] [Related]
2. Comparison of the stability of split and intact gabapentin tablets. Volpe DA; Gupta A; Ciavarella AB; Faustino PJ; Sayeed VA; Khan MA Int J Pharm; 2008 Feb; 350(1-2):65-9. PubMed ID: 17935918 [TBL] [Abstract][Full Text] [Related]
3. Stability of gabapentin in extemporaneously compounded oral suspensions. Friciu M; Roullin VG; Leclair G PLoS One; 2017; 12(4):e0175208. PubMed ID: 28414771 [TBL] [Abstract][Full Text] [Related]
4. FDA approves gabapentin prodrug as restless legs treatment. Thompson CA Am J Health Syst Pharm; 2011 May; 68(10):862. PubMed ID: 21546634 [No Abstract] [Full Text] [Related]
5. Development of two stable oral suspensions for gabapentin. Nahata MC Pediatr Neurol; 1999 Mar; 20(3):195-7. PubMed ID: 10207927 [TBL] [Abstract][Full Text] [Related]
6. Comparative stability of repackaged metoprolol tartrate tablets. Yang Y; Gupta A; Carlin AS; Faustino PJ; Lyon RC; Ellison CD; Rothman B; Khan MA Int J Pharm; 2010 Jan; 385(1-2):92-7. PubMed ID: 19879937 [TBL] [Abstract][Full Text] [Related]
8. Stability of ranitidine syrup re-packaged in unit-dose containers. Shah RB; Prasanna HR; Rothman B; Khan MA Am J Health Syst Pharm; 2008 Feb; 65(4):325-9. PubMed ID: 18238770 [TBL] [Abstract][Full Text] [Related]
9. Abuse potential of gabapentin in dentistry. Weinberg MA; Segelnick SL; Insler JS Gen Dent; 2017; 65(6):73-75. PubMed ID: 29099371 [TBL] [Abstract][Full Text] [Related]
10. Comparative study on the bioequivalence of two different gabapentin formulations. A randomised, two-period, two-sequence, crossover clinical trial in healthy volunteers. Almeida S; Filipe A; Almeida A; Antonijoan R; García-Gea C; Gich I; Barbanoj M; Cruz Caturla M Arzneimittelforschung; 2006; 56(2):59-63. PubMed ID: 16572918 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of gabapentin in horses. Dirikolu L; Dafalla A; Ely KJ; Connerly AL; Jones CN; ElkHoly H; Lehner AF; Thompson K; Tobin T J Vet Pharmacol Ther; 2008 Apr; 31(2):175-7. PubMed ID: 18307511 [No Abstract] [Full Text] [Related]
12. In Vitro/in vivo relationship of gabapentin from a sustained-release tablet formulation: a pharmacokinetic study in the beagle dog. Rhee YS; Park S; Lee TW; Park CW; Nam TY; Oh TO; Jeon JW; Han SB; Lee DS; Park ES Arch Pharm Res; 2008 Jul; 31(7):911-7. PubMed ID: 18704335 [TBL] [Abstract][Full Text] [Related]
14. Stability of gabapentin in SyrSpend SF. Sorenson B; Voudrie MA; Gehrig D Int J Pharm Compd; 2012; 16(4):347-9. PubMed ID: 23050395 [TBL] [Abstract][Full Text] [Related]
15. Stability of three oral liquid drug products repackaged in unit dose containers. Christensen JM; Lee RY; Parrott KA Am J Hosp Pharm; 1983 Apr; 40(4):612-5. PubMed ID: 6846370 [TBL] [Abstract][Full Text] [Related]
16. Effects of packaging and storage on the dissolution of model prednisone tablets. Taborsky-Urdinola CJ; Gray VA; Grady LT Am J Hosp Pharm; 1981 Sep; 38(9):1322-7. PubMed ID: 7282715 [TBL] [Abstract][Full Text] [Related]
18. The analgesic effect of gabapentin as a prophylactic anticonvulsant drug on postcraniotomy pain: a prospective randomized study. Türe H; Sayin M; Karlikaya G; Bingol CA; Aykac B; Türe U Anesth Analg; 2009 Nov; 109(5):1625-31. PubMed ID: 19713257 [TBL] [Abstract][Full Text] [Related]
19. Prochlorperazine tablets repackaged into dose administration aids: can the patient be assured of quality? Glass B; Mangan M; Haywood A J Clin Pharm Ther; 2009 Apr; 34(2):161-9. PubMed ID: 19250136 [TBL] [Abstract][Full Text] [Related]